1 EINLEITUNG UND HYPOTHESEN - Universität zu Lübeck

LITERATURVERZEICHNIS
6 LITERATURVERZEICHNIS
Aguilera G, Rabadan-Diehl C, Nikodemova M. Regulation of pituitary corticotropin
releasing hormone receptors. Peptides 2001;22:769-74.
Ahren B. Autonomic regulation of islet hormone secretion--implications for health and
disease. Diabetologia 2000;43:393-410.
Allison SP, Hinton P, Chamberlain MJ. Intravenous glucose-tolerance, insulin, and freefatty-acid
levels in burned patients. Lancet 1968;2:1113-6.
Alonso G, Szafarczyk A, Balmefrezol M, Assenmacher I. Immunocytochemical evidence
for stimulatory control by the ventral noradrenergic bundle of parvocellular neurons of the
paraventricular nucleus secreting corticotropin releasing hormone and vasopressin in rats.
Brain Res 1986;397:297-307.
Azarbayjani MA, Vaezepor F, Rasaee MJ et al. Daily timing of salivary cortisol responses
and aerobic performance in lean and obese active females. Bratisl Lek Listy 2011;112:213-
7.
Bell RA, Summerson JH, Spangler JG, Konen JC. Body fat, fat distribution, and
psychosocial factors among patients with Type 2 diabetes mellitus. Behav Med
1998;24:138-43.
Billaudel B, Sutter BC. Effect of corticosterone upon insulin biosynthesis and storage by
isolated rat Langerhans islets. Diabete Metab 1982;8:283-7.
Block JP, He Y, Zaslavsky AM, Ding L, Ayanian JZ. Psychosocial stress and change in
weight among US adults. Am J Epidemiol 2009;170:181-92.
Bruehl H, Rueger M, Dziobek I et al. Hypothalamic-pituitary-adrenal axis dysregulation
and memory impairments in type 2 diabetes. J Clin Endocrinol Metab 2007;92:2439-45.
Burdakov D, Jensen LT, Alexopoulos H et al. Tandem-pore K+ channels mediate
inhibition of orexin neurons by glucose. Neuron 2006;50:711-22.
Caballero B. The global epidemic of obesity: an overview. Epidemiol Rev 2007;29:1-5.
37